Search

Preeclampsia (PE), a complication of pregnancy that is characterized by de novo hypertension and proteinuria, remains a leading cause of morbidity and mortality during pregnancy, influencing 2.5-7% of singleton and 7-21% of twin pregnancies. At present, diagnosis is based on traditional but unreliable and nonspecific clinical markers, and treatment of PE is suboptimal, with minimal effect on maternal and fetal mortality and morbidity. With the hope of developing an affordable and simple procedure for PE prediction for developing countries, a previous study examined the use of Congo red staining of misfolded and damaged proteins in the urine of women with PE. This feature has diagnostic and prognostic potential since it precedes the onset of clinical manifestations and correlates with disease severity. The test is inexpensive, popular within the medical staff, easy to use, and identifies women with PE in only 3 min. Obstetrical providers benefit from the Congo Red Dot Paper Test analysis, since a negative result promotes lesser waiting times in triage, prevents unneeded admissions, and diminishes the health costs associated per case. [ABSTRACT FROM AUTHOR]

The article focuses on the retraction of a study on pyrroloquinoline quinone's radioprotective effects in mice due to concerns over the use of edited and duplicated images of mice from a previously published paper.

The article titled "[Retracted] Mammalian STE20-like kinase 1 regulates pancreatic cancer cell survival and migration through Mfn2-mediated mitophagy" has been retracted from the journal Molecular Medicine Reports. Concerns were raised by a reader regarding the similarity of certain images and data in the article to previously published work by different authors. The editor decided to retract the paper due to a lack of confidence in the presentation of the data and the authors' failure to provide an explanation. The retraction is regrettable and may cause inconvenience to readers. [Extracted from the article]

The article titled "[Retracted] Methylene blue relieves the development of osteoarthritis by upregulating lncRNA MEG3" has been retracted by the journal Experimental & Therapeutic Medicine. The retraction was prompted by the discovery that the histological images and western blotting data presented in the article were similar to data from other articles published by different authors at different research institutes. The authors of the article accepted the decision to retract the paper, and the editor of the journal apologizes for any inconvenience caused. [Extracted from the article]

This article, titled "[Retracted] Reduced miR-202 levels enhanced oral cancer development via targeting Sp1," was published in the journal Experimental & Therapeutic Medicine in 2019. However, it has since been retracted due to concerns raised by a reader. The reader pointed out that certain data in the article appeared to be similar to data from other articles published by different authors at different research institutes. After discussing the matter with the authors, the editor decided to retract the paper. The editor apologizes for any inconvenience caused. [Extracted from the article]

The article titled "[Retracted] The AMPK-mTOR axis requires increased MALAT1 expression for promoting granulosa cell proliferation in endometriosis" has been retracted by the journal Experimental & Therapeutic Medicine. Concerns were raised by a reader regarding the similarity of data in Figures 2C, 4A, and 6E to data published in other articles by different authors at different research institutes. As a result, the editor decided to retract the paper, and the authors accepted this decision. The journal apologizes for any inconvenience caused. [Extracted from the article]

The article titled "[Retracted] Liraglutide repairs the infarcted heart: The role of the SIRT1/Parkin/mitophagy pathway" was published in Molecular Medicine Reports in 2018 but has since been retracted. The retraction was prompted by a concerned reader who noticed similarities between the data presented in the article and data from other articles written by different authors at different research institutes. The editor of Molecular Medicine Reports decided to retract the paper, and the authors agreed with this decision. The retraction is an acknowledgment of the potential overlap in previously published data. [Extracted from the article]

The article titled "[Retracted] Anthelmintic drug albendazole arrests human gastric cancer cells at the mitotic phase and induces apoptosis" has been retracted from the journal Experimental & Therapeutic Medicine. A concerned reader brought to the editor's attention that there were similarities in the data presented in the flow cytometric experiments that were difficult to attribute to coincidence. After an internal investigation, the editor verified the claims and decided to retract the paper due to a lack of confidence in the presented data. The authors were contacted and accepted the decision to retract the paper, except for one author who could not be reached. The editor apologizes for any inconvenience caused. [Extracted from the article]

The article titled "[Retracted] Dexmedetomidine improves early postoperative neurocognitive disorder in elderly male patients undergoing thoracoscopic lobectomy" has been retracted by the Editor of Experimental and Therapeutic Medicine due to concerns raised by a reader. The article was found to have unexpected similarities with a pre-print article that has not been formally submitted for publication. The pre-print article has since been retracted by Research Square. The Editor decided to retract the article from the Journal due to a lack of confidence in the presented data. The authors accepted the decision to retract the paper. [Extracted from the article]

This article, titled "[Retracted] Tumor suppressor miR-613 induces cisplatin sensitivity in non-small cell lung cancer cells by targeting GJA1," was published in Molecular Medicine Reports in 2021. However, it has since been retracted due to concerns raised by a reader. The reader pointed out that certain data in the article, including colony formation assay data, tumor images, and migration assay data, were similar to data from other papers by different authors at different research institutes. The authors were asked for an explanation but did not respond. The editor has apologized for any inconvenience caused. [Extracted from the article]

The article titled "[Retracted] Galectin-3 blockade suppresses the growth of cetuximab-resistant human oral squamous cell carcinoma" has been retracted from the journal Molecular Medicine Reports. A concerned reader brought to the editor's attention that the colony formation assay data in Figure 4C on page 6 were similar to data published in other articles by different authors at different research institutes. Since the contentious data had already been published before submission to the journal, the editor decided to retract the paper. The authors accepted the decision, and the editor apologizes for any inconvenience caused. [Extracted from the article]

The article focuses on the retraction of a study on microRNA-17-5p's role in osteoarthritis due to concerns about the use of duplicated western blotting data and diagram elements from a previously submitted paper.

The article titled "[Retracted] MicroRNA-106a-5p promotes the proliferation, autophagy and migration of lung adenocarcinoma cells by targeting LKB1/AMPK" has been retracted by the journal Experimental & Therapeutic Medicine. Concerns were raised by a reader regarding the similarity of certain data in the article to data published in other articles by different authors at different research institutes. The editor of the journal decided to retract the paper due to the apparent prior publication of the data. The authors were asked for an explanation but did not respond. The journal apologizes for any inconvenience caused. [Extracted from the article]

This article, published in Oncology Letters, discusses the role of ATP-binding cassette transporter A7 (ABCA7) in promoting epithelial-to-mesenchymal transition (EMT) in ovarian cancer cells by upregulating the transforming growth factor-β (TGF-β) signaling pathway. However, the paper has been retracted due to concerns raised by a reader regarding the similarity of certain data in Figure 4C to data published in another article by different authors. The authors were asked for an explanation but did not respond. The Editor has decided to retract the paper and apologizes for any inconvenience caused. [Extracted from the article]

This article, titled "[Retracted] Nicotinamide N‑methyltransferase promotes epithelial‑mesenchymal transition in gastric cancer cells by activating transforming growth factor‑β1 expression," was published in Oncology Letters in 2018. However, it has since been retracted due to concerns raised by a reader. The reader pointed out that the western blotting data, scratch-wound assay data, and migration and invasion assay data presented in the article were similar to data from previously published articles by different authors or articles submitted for publication around the same time. Additionally, two data panels in the cell morphological images were found to be overlapping. The authors accepted the decision to retract the paper, and the editor apologizes for any inconvenience caused. [Extracted from the article]

[Retracted] Inhibition of RKIP aggravates thioacetamide-induced acute liver failure in mice Following an internal enquiry, the Editor of I Experimental and Therapeutic Medicine i has been able to verify the claims made by the interested reader; therefore, in view of the number of potential anomalies that have been identified and owing to a lack of overall confidence in the presented data, the Editorial Board have decided to retract the above paper from the publication. Exp Ther Med 16:2992-2998, 2018; DOI: 10.3892/etm.2018.6542 Following the publication of the above paper, an interested reader drew to our attention that a number of apparent anomalies existed with the data presented in the above paper. [Extracted from the article]

The article titled "[Retracted] Downregulated expression levels of USP46 promote the resistance of ovarian cancer to cisplatin and are regulated by PUM2" was published in Molecular Medicine Reports in 2021. However, it has since been retracted by the editor due to concerns raised by a reader. The reader pointed out that certain data in the article appeared to be similar to data from other papers under consideration for publication at the same time. The authors were asked for an explanation but did not respond. The editor apologizes for any inconvenience caused. [Extracted from the article]

This article, titled "[Retracted] MicroRNA-378 regulates cell proliferation and migration by repressing RNF31 in pituitary adenoma," was published in Oncology Letters in 2018. However, it has since been retracted due to concerns raised by a reader. The reader pointed out similarities between the scratch-wound assay data in Figure 3 of this article and data from a different paper submitted to the same journal. Additionally, there were possible anomalies in the "Control" panel. The editor decided to retract the paper due to a lack of confidence in the data and the authors did not provide an explanation. [Extracted from the article]

The article titled "[Retracted] MicroRNA-338-3p suppresses cell proliferation, migration and invasion in human malignant melanoma by targeting MACC1" has been retracted from the journal Experimental & Therapeutic Medicine. Concerns were raised by a reader regarding the similarity of certain data in the article to data published in other articles by different authors at different research institutes. The editor of the journal decided to retract the paper due to the apparent publication of the data previously. The authors were asked for an explanation but did not respond. The editor apologizes for any inconvenience caused. [Extracted from the article]

The article titled "[Retracted] Knockdown of circ_0001883 may inhibit epithelial-mesenchymal transition in laryngeal squamous cell carcinoma via the miR-125-5p/PI3K/AKT axis" has been retracted by the journal Experimental & Therapeutic Medicine. Concerns were raised by a reader regarding the similarity of certain data and images in the article to previously published work by different authors. The editor of the journal decided to retract the paper due to the apparent publication of some of the data prior to its submission. The authors were given an opportunity to respond but did not provide an explanation. The editor apologizes for any inconvenience caused. [Extracted from the article]

The article titled "[Retracted] Chelerythrine chloride induces apoptosis in renal cancer HEK-293 and SW-839 cell lines" was published in the journal Oncology Letters in 2016. However, it has since been retracted due to concerns raised by a reader regarding the similarity of certain western blotting data in Figure 4Ba to data previously published in another journal. The authors of the article requested the retraction, and the Editor decided to retract the paper due to a lack of confidence in the presented data. The Editor apologizes for any inconvenience caused. [Extracted from the article]

The article titled "[Retracted] Effects of Grb2-associated binding protein 2-specific siRNA on the migration and invasion of MG-63 osteosarcoma cells" was retracted from the journal Oncology Letters. A concerned reader brought to the editor's attention that certain data in the article were similar to data that had already been published by different authors. The editor decided to retract the paper because the contentious data had been published prior to its submission. The authors were asked for an explanation but did not provide a satisfactory reply. The editor apologizes for any inconvenience caused. [Extracted from the article]

The article titled "[Retracted] miR-143-5p suppresses breast cancer progression by targeting the HIF-1α-related GLUT1 pathway" was published in Oncology Letters in 2022. However, a concerned reader brought to the attention of the Editorial Office that some of the data presented in Figure 6F had already been published in a different paper by different authors. As a result, the Editor decided to retract the article from the journal. The authors were asked for an explanation but did not respond. The Editor apologizes for any inconvenience caused. [Extracted from the article]

This article, titled "[Retracted] HCV-E2 inhibits hepatocellular carcinoma metastasis by stimulating mast cells to secrete exosomal shuttle microRNAs," was published in Oncology Letters in 2017. However, it has since been retracted due to concerns raised by a reader. The reader pointed out that certain data in the article's figures were strikingly similar to data that had already been published in another article by different authors. The authors were asked for an explanation but did not respond. The editor has therefore decided to retract the paper from the journal. [Extracted from the article]

The article titled "[Retracted] miR-613 suppresses migration and invasion in esophageal squamous cell carcinoma via the targeting of G6PD" has been retracted by the Editor of Experimental & Therapeutic Medicine due to concerns raised by a reader. The reader pointed out that the data presented in Figure 6B of the article were similar to data from other articles written by different authors at different research institutes. Additionally, overlapping data panels were identified in Figure 6A, suggesting that the results were derived from the same original source. The authors agreed with the decision to retract the paper. [Extracted from the article]

The article titled "[Retracted] MicroRNA-139-5p inhibits cell viability, migration and invasion and suppresses tumor growth by targeting HDGF in non-small cell lung cancer" was published in the journal Oncology Letters in 2020. However, it has since been retracted due to concerns raised by a reader. The reader pointed out that there were instances of overlapping data panels in the Transwell migration assay experiments, suggesting that the data may have been derived from the same source. Additionally, some of the data from the invasion assay experiments appeared in another paper published by different authors. The editor of Oncology Letters decided to retract the paper due to an overall lack of confidence in the presented data. [Extracted from the article]

J Transl Med 13: 59, 2015; and Zhang M, Wang L, Dong M, Li Z and Jin F: Endothelial semaphorin 7A promotes inflammation in seawater aspiration-induced acute lung injury. Exp Ther Med 15:2356-2364, 2018; DOI: 10.3892/etm.2018.5724 Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that the vWF data presented in Fig. [Retracted] Anti-Semaphorin-7A single chain antibody demonstrates beneficial effects on pulmonary inflammation during acute lung injury. [Extracted from the article]

The article titled "[Retracted] Germacrone cooperates with dexmedetomidine to alleviate high-fat diet-induced type 2 diabetes mellitus via upregulating AMPKα1 expression" has been retracted by the journal Experimental & Therapeutic Medicine. Concerns were raised by a reader regarding the similarity of certain images and data in the article to those in other articles by different authors at different research institutes. As a result, the editor decided to retract the paper. The authors were asked for an explanation but did not respond. The editor apologizes for any inconvenience caused. [Extracted from the article]

This article, titled "[Retracted] miR-124 inhibits proliferation, migration and invasion of malignant melanoma cells via targeting versican," was published in the journal Experimental & Therapeutic Medicine in 2017. However, it has since been retracted due to concerns raised by a reader. The reader pointed out that certain data in the article appeared to be similar to data from other articles written by different authors at different research institutes. The editor of the journal decided to retract the paper, and despite being asked for an explanation, the authors did not respond. The editor apologizes for any inconvenience caused. [Extracted from the article]

This article, titled "[Retracted] MicroRNA-203 inhibits malignant melanoma cell migration by targeting versican," was published in the journal Experimental & Therapeutic Medicine in 2014. However, it has since been retracted due to concerns raised by a reader. The reader pointed out that the western blotting data and Transwell migration assay data presented in the article were similar to data from other articles written by different authors at different research institutes. The editor of the journal decided to retract the paper, and the authors did not provide an explanation for these concerns. The editor apologizes for any inconvenience caused. [Extracted from the article]

The article titled "[Retracted] Rapamycin suppresses the PI3K/AKT/mTOR signaling pathway by targeting SIRT1 in esophageal cancer" has been retracted by the journal Experimental & Therapeutic Medicine. A concerned reader brought to the editor's attention that the tumor images in Figure 5B were similar to data from other articles published by different authors at different research institutes. The contentious data had already been published before its submission to the journal. The authors agreed with the decision to retract the paper, and the editor apologizes for any inconvenience caused. [Extracted from the article]

This document is a corrigendum for an article titled "[Corrigendum] Downregulated caveolin-1 expression serves a potential role in coronary artery spasm by inducing nitric oxide production in vitro." The authors of the article have identified an error in Figure 2, where the GAPDH western blot control bands appeared incorrectly in the printed version. The authors have examined their original data, identified the correct blots, and provided a corrected version of Figure 2. They emphasize that this error does not affect the overall conclusions of the paper. The authors apologize for any inconvenience caused and express gratitude to the editor for allowing them to publish this corrigendum. [Extracted from the article]

This article, titled "[Retracted] MicroRNA-454-3p inhibits cervical cancer cell invasion and migration by targeting c-Met," was published in the journal Experimental & Therapeutic Medicine in 2018. However, the article has since been retracted due to concerns raised by a reader regarding the data presented in Figure 4A. The reader noticed that several of the data panels appeared to be overlapping, suggesting that the data may have been derived from a smaller number of original sources. After conducting an independent investigation, the Editorial Office confirmed the validity of these concerns and decided to retract the paper. The authors were asked for an explanation but did not respond. The Editor apologizes for any inconvenience caused. [Extracted from the article]

This document is a corrigendum for a paper published in the journal Molecular Medicine Reports. The authors acknowledge an error in Figure 2A of the original publication, where there was an unintentional duplication of an image and incorrect sample numbers. The revised version of Figure 2, which shows the correct data, is provided. The authors state that these errors did not significantly impact the results or conclusions of the paper. They emphasize the importance of a larger sample size for future studies and apologize for any inconvenience caused. The document also includes a graph and data on the expression levels of centromere protein M (CENPM) in various types of human cancer. [Extracted from the article]

This document is a corrigendum for an article titled "miR-199b-5p serves as a tumor suppressor in renal cell carcinoma" published in the journal Experimental & Therapeutic Medicine. The corrigendum addresses an error in Figure 5A of the original article, where two data panels appeared to show overlapping data from the same source instead of different experiments. The authors have re-examined their data and provided a corrected version of Figure 5. They emphasize that this error does not affect the overall conclusions of the paper. The authors apologize for any inconvenience caused and express gratitude to the editor for allowing them to publish this corrigendum. [Extracted from the article]

This document is a corrigendum for an article titled "Relationship between changes in mitochondrial function and hippocampal neuronal apoptosis after recurrent convulsion during developmental stage." The authors of the article discovered that they mistakenly used the same control GAPDH bands in Figures 3 and 5. They have provided corrected versions of the figures and stated that this error did not impact the overall conclusions of the paper. The authors apologize for any inconvenience caused. The article was authored by Yueying Liu, Jieru Chen, Meifang Jin, Zhenhong Li, Tian Tian, Lili Li, and Hong Ni. [Extracted from the article]

The authors were contacted in this regard, but did not offer any rebuttal in light of the Editor's decision to retract this paper. Oncol Lett 10: 77-84, 2015; DOI: 10.3892/ol.2015.3242 Subsequently to the publication of the above paper, it has been brought to the attention of the Editor that there were a number of striking similarities between the article and another paper published in a different journal by different authors located at different research institutions. [Extracted from the article]

Exp Ther Med 22:933, 2021; DOI: 10.3892/etm.2021.10365 Following the publication of the above paper, the authors wish to publish a Corrigendum to account for a necessary change in the authorship on the paper. Therefore, the revised authors' names on this paper, together with their affiliations, are as follows: WEN-BIN LIU SP 1* sp , GUI-SHI LI SP 2 sp , PENG SHEN SP 3 sp , YA-NAN LI SP 4 sp and FU-JIANG ZHANG SP 1 sp SP 1 sp Department of Joint Surgery, Tianjin Hospital, Tianjin 300211; SP 2 sp Department of Joint Surgery, Yuhuangding Hospital, Yantai, Shandong 264000; SP 3 sp Department of Rheumatology and Immunology, Tianjin First Center Hospital, Tianjin 300192; SP 4 sp Department of Orthopedics, Tianjin Dongli Hospital, Tianjin 300300, P.R. China The authors are grateful to the Editor of I Experimental and Therapuetic Medicine i for allowing them the opportunity to publish this Corrigendum, and apologize for any inconvenience caused. [Extracted from the article]